Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer

NCT03611179 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Advanced Ovarian Cancer

Interventions

DRUG: Bevacizumab

Sponsor

Nada Hassan Salah

Collaborators

[object Object]